Product Information
ALISKIREN 150 MG TABLET is a generic product labeled by Endo USA Inc., priced at $4.0474 per EA under NDC 49884042411. Its NADAC has been published 379 times since May 22, 2019.
FDA first approved this application on Mar 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Endo USA Inc.NDC
49884042411
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALISKIREN HEMIFUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206665FDA Approved
3/22/2019
TE Code
AB
On Market Since
3/25/2019
Pharmacological Classes
Price Statistics
The NADAC for ALISKIREN 150 MG TABLET has been published 379 times since May 22, 2019, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0474 per EA |
|---|---|
| All-time high | $6.0323 (Jul 15, 2020) |
| All-time low | $3.5677 (Jun 19, 2024) |
| 52-week high | $4.3921 |
| 52-week low | $4.0009 |
| Median price | $5.0066 |
| Average price | $5.0325 |
| Largest weekly change | -26.2% (Mar 22, 2023) |
| Weeks tracked | 379 |
| Tracking since | May 22, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ALISKIREN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALISKIREN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALISKIREN 150 MG TABLET, manufactured by Endo USA Inc., is $4.0474 per EA (NDC 49884042411), effective Aug 19, 2026.
How has the price of ALISKIREN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALISKIREN 150 MG TABLET has declined 31.6%. It has been tracked across 379 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for ALISKIREN 150 MG TABLET?
Since May 22, 2019, the NADAC for ALISKIREN 150 MG TABLET has ranged from a low of $3.5677 (Jun 19, 2024) to a high of $6.0323 (Jul 15, 2020), with a median of $5.0066 per EA.
Are there cheaper alternatives to ALISKIREN 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ALISKIREN 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALISKIREN 150 MG TABLET?
ALISKIREN 150 MG TABLET (NDC 49884042411) is labeled by Endo USA Inc., and CMS classifies it as a generic product.